--BioVaxys Technology Corp. is pleased to announce that it has been invited to and joined The Rapid Response Partnership Vehicle, a consortium of large and small biopharma, contractors, government ...

News about Biomedical Advanced Research and Development Authority. Commentary and archival information about Biomedical Advanced Research and Development Authority from The New York Times.

We are very pleased to receive the continued funding under the OTA with BARDA to support the development of our antifungal drug candidates fosmanogepix and BAL2062. Both compounds offer a novel ...

The Biden administration awarded the vaccine manufacturer a $590 million grant in January from the Biomedical Advanced Research and Development Authority. The funding followed another $176 million ...

Morningstar brands and products Company Portfolio ...

BioVaxys to Participate in the US Government Biomedical Advanced Research and Development Authority (BARDA) Rapid Response Partnership Vehicle (RRPV) Vaccine Development Consortium Nov. 05, 2024 5 ...

Detailed price information for Biovaxys Technology Corp (BVAXF) from The Globe and Mail including charting and trades.